Moreover, FLT3 inhibitors have been found to have a therapeutic effect in (human) cell and mouse models of Rett syndrome, a genetically determined neurodevelopmental disorder [230], and to alleviate peripheral neuropathic pain in mice [231]. Here, FLT3 is linked to atypical Rett syndrome.